Gene therapies replace or modify disease-causing genes in human cells. In this report, CBO discusses how it would estimate the budgetary effects of policies that sought to increase the use of gene therapy treatment for sickle cell disease.
December 2024
CBO provides an overview of the channels through which the adoption of artificial intelligence could affect the U.S. economy and the federal budget.
CBO assesses how climate change will pose risks to the United States through its effects on economic activity, real estate and financial markets, human health, biodiversity, immigration, and national security.
CBO provides details about its latest projections of the economy through 2027. Those projections reflect economic developments and current law as of December 4, 2024.
This primer summarizes the practices that CBO follows when incorporating the effects of recent administrative and judicial actions in its baseline projections and cost estimates.
CBO periodically issues a compendium of policy options and their estimated effects on the federal budget. This report presents 76 options for altering spending or revenues to reduce federal budget deficits over the next decade.
CBO estimates how expanding certain children’s eligibility for Medicaid or the Children’s Health Insurance Program over the next 10 years would affect the U.S. economy and the federal budget through the end of the century.
This report presents CBO’s projections of revenues and outlays for the 2025–2034 period translated into the framework of the national income and product accounts and their categories of current receipts and expenditures.
The federal budget deficit totaled $622 billion in October and November 2024, the first two months of fiscal year 2025, CBO estimates. That amount is $242 billion more than the deficit recorded during the same period last fiscal year.
CBO assesses the quality of the baseline projections of deficits and debt that it has made each spring from 1984 to 2023.